# Esplanade Ventures

Esplanade Ventures is a Venture Capital based in Westmount, Canada.

## Overview

- **Organization type:** Venture Capital
- **Headquarters:** Westmount, Canada
- **Region:** North America
- **Address:** 1310 Greene Avenue, Suite 810, Westmount, Quebec, Canada
- **Founded:** 2019
- **Assets under management:** Undisclosed
- **Website:** esplanadeventures.com
- **LinkedIn:** https://www.linkedin.com/company/esplanadeventures

## Regulatory record

- **Reports private funds:** No

## About

Esplanade Ventures is a venture capital firm focused on digital health within the healthcare sector. It invests in early-stage technology companies in North America, with a preference for AI-enabled solutions affecting patients or healthcare professionals. Founded in 2019 in Montreal, Canada, Esplanade Ventures has made 23 investments and achieved 2 portfolio exits.

## Sectors

- Digital Health
- AI/ML

## Offices

- Toronto, Ontario, Canada

## People

- Dr. Sheldon Elman, MD — Co-Founder & Chairman
- Stuart M. Elman — Co-Founder
- Ella Seitz — Managing Partner
- Josh Blair — Venture Partner
- Alexandre Nossovskoi — Principal

## Questions

### Who runs investment decisions at Esplanade Ventures?

Co-Founders Dr. Sheldon Elman and Stuart Elman oversee the firm's strategy and investment decisions alongside Managing Partner Ella Seitz and Venture Partner Josh Blair. The firm operates with a lean team of nine, including Principal Alexandre Nossovskoi. No external investment committee structure is publicly disclosed.

### How does Esplanade Ventures source proprietary deal flow?

Esplanade sources opportunities through a network built on decades of healthcare operations. The founding team's clinical and management experience provides direct access to hospital systems, healthtech founders, and clinical validators across North America and Israel. The firm does not publicly disclose a systematic outbound sourcing program, but its operator-led thesis prioritizes deals surfaced through practitioner networks rather than traditional venture pipelines.

### What investment stages and check sizes does Esplanade Ventures target?

Esplanade invests from Seed through Series A, with selective follow-on participation in Series B rounds. The firm leads or co-leads early-stage rounds in digital health companies focused on North American commercialization. It does not reveal standard check sizes or reserve ratios.

### Which sectors does Esplanade Ventures avoid?

The firm states explicitly on its website that it does not invest in invasive medical devices or biotechnology. Esplanade concentrates solely on digital health, with a preference for AI-enabled software platforms. It maintains no exposure to hardware, life sciences, or therapeutic development.

### Where does the founding expertise of Esplanade Ventures originate?

Chairman Dr. Sheldon Elman brings over 45 years in healthcare, while Co-Founder Stuart Elman adds 20 years. Venture Partner Josh Blair contributes 15 years in healthtech from his tenure at TELUS, one of Canada's largest healthcare IT providers. The firm markets itself as 'healthcare operators backing healthcare innovators' rather than career investors entering the space.

### What is Esplanade Ventures' geographic mandate?

Esplanade targets companies commercializing in North America, with a team and network that extend to Europe and Israel. The dual-office structure in Montreal and Toronto supports Canadian deal flow, but the firm actively seeks U.S.-focused opportunities. It does not disclose formal allocations by country or region.

## Related profiles

- [ESPIRA Investments](https://altss.com/profile/espira-investments)
- [ESPMgmt](https://altss.com/profile/espmgmt)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/esplanade-ventures

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology